louisiana tirzepatide law firm Civil Treatise V.2 Property, 2025-2026 ed Louisiana Ozempic Lawyer | Injury

Dual GIP/GLP-1 receptor agonist

Australian Peptide supplies Retatrutide exclusively for scientific research and analytical laboratory applications, with batch identification and supporting documentation where applicable

Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptorsGLP-1, GIP, and glucagonpositioning it as a next-generation triple agonist. In research settings, it has been examined for its potential influence on appetite regulation, energy utilization, and body-weightrelated endpoints

Tirzepatide is a dual action GLP-1 and GIP receptor agonist

Not everyone needs or wants the full clinical dose to experience benefits